I don’t see any details that tells me that the Ascend sirolimus tablet is enteric coated.
Rapamycin / Sirolimus is destroyed in the gastro intestinal track if its not protected, so the medicine wouldn’t work for its primary purpose (preventing organ rejection) if it didn’t have some sort of protective covering on the tablet. So, since its approved by the FDA I’m assuming that it must have some protective covering, and because otherwise people would be rejecting their transplanted organs and dying…
If you really are still not confident in the product, you can get a blood sirolimus test after taking it so you know its getting into your blood stream, see this thread: How to get a Rapamycin (sirolimus) Blood Level Test
Or you can research more on the tablet ingredients - here is a full list:
PRODUCT DETAILS
WHAT IS NDC 67877-746?
The NDC code 67877-746 is assigned by the FDA to the product Sirolimus which is a human prescription drug product labeled by Ascend Laboratories, Llc. The product’s dosage form is tablet and is administered via oral form. The product is distributed in 4 packages with assigned NDC codes 67877-746-01 100 tablet in 1 bottle , 67877-746-05 500 tablet in 1 bottle , 67877-746-30 30 tablet in 1 bottle , 67877-746-38 100 blister pack in 1 carton / 10 tablet in 1 blister pack (67877-746-33). This page includes all the important details about this product, including active and inactive ingredients, pharmagologic classes, product uses and characteristics, UNII information and RxNorm crosswalk.
WHAT ARE THE USES FOR SIROLIMUS?
Sirolimus is used with other medications to prevent rejection of a kidney transplant. This medication belongs to a class of drugs known as immunosuppressants. It works by weakening your body’s defense system (immune system) to help your body accept the new organ as if it were your own. Sirolimus may also be used to treat a certain lung disease (lymphangioleiomyomatosis-LAM).
WHAT ARE SIROLIMUS ACTIVE INGREDIENTS?
An active ingredient is the substance responsible for the medicinal effects of a product specified by the substance’s molecular structure or if the molecular structure is not known, defined by an unambiguous definition that identifies the substance. Each active ingredient name is the preferred term of the UNII code submitted.
-
SIROLIMUS .5 mg/1 - A macrolide compound obtained from Streptomyces hygroscopicus that acts by selectively blocking the transcriptional activation of cytokines thereby inhibiting cytokine production. It is bioactive only when bound to IMMUNOPHILINS. Sirolimus is a potent immunosuppressant and possesses both antifungal and antineoplastic properties.
WHICH ARE SIROLIMUS UNII CODES?
The UNII codes for the active ingredients in this product are:
WHICH ARE SIROLIMUS INACTIVE INGREDIENTS UNII CODES?
The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym “UNII” stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product. The UNII codes for the inactive ingredients in this product are:
Source: https://ndclist.com/ndc/67877-746